DENVER--(BUSINESS WIRE)--Ceragenix Pharmaceuticals, Inc. (OTCB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that five poster presentations on the efficacy of its Ceragenin™ technology have been accepted for presentation at the upcoming annual meeting of the American Society for Microbiology’s Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) to be held September 17th to 20th in Chicago, Illinois.
